{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Scottsdale",
      "state": "AZ",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "63917",
      "recalling_firm": "Matrixx Initiatives Inc",
      "address_1": "8515 E Anderson Dr",
      "address_2": "N/A",
      "postal_code": "85255-5461",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide.",
      "recall_number": "D-155-2013",
      "product_description": "Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona  85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0.",
      "product_quantity": "46,752 bottles",
      "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.",
      "recall_initiation_date": "20121218",
      "center_classification_date": "20130207",
      "termination_date": "20131114",
      "report_date": "20130213",
      "code_info": "Lot # 2J23, Exp 09/15",
      "more_code_info": ""
    }
  ]
}